Eutirox | Health Canada | Drug Product Database | DPD | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Eutirox
Canada

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

Contact Supplier

Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

Contact Supplier

jdmfs-not-supported-m-2025-06-23

Eutirox

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

42 API Suppliers, 15 USDMF, 10 CEP/COS, 2 JDMF, 4 EU WC, 5 KDMF, 19 NDC API, 15 Listed Suppliers, $ API Reference Price

42 API Suppliers
15 USDMF
10 CEP/COS
2 JDMF
4 EU WC
5 KDMF
19 NDC API
15 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

10 Drugs in Development

10 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

618 FDF Dossiers, 267 FDA Orange Book, 185 Europe, 41 Canada, 37 Australia, 33 South Africa, 55 Listed Dossiers

618 FDF Dossiers
267 FDA Orange Book
185 Europe
41 Canada
37 Australia
33 South Africa
55 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 0.0125MG;0.0031MG, TABLET;ORAL - 0.025MG;0.0063MG, TABLET;ORAL - 0.05MG;0.0125MG, TABLET;ORAL - 0.15MG;0.0375MG, TABLET;ORAL - 0.1MG;0.025MG, POWDER;INTRAVENOUS - 100MCG/VIAL, POWDER;INTRAVENOUS - 200MCG/VIAL, POWDER;INTRAVENOUS - 500MCG/VIAL, TABLET;ORAL - 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, CAPSULE;ORAL - 0.013MG, CAPSULE;ORAL - 0.025MG, CAPSULE;ORAL - 0.0375MG, CAPSULE;ORAL - 0.044MG, CAPSULE;ORAL - 0.05MG, CAPSULE;ORAL - 0.0625MG, CAPSULE;ORAL - 0.075MG, CAPSULE;ORAL - 0.088MG, CAPSULE;ORAL - 0.112MG, CAPSULE;ORAL - 0.125MG, CAPSULE;ORAL - 0.137MG, CAPSULE;ORAL - 0.15MG, CAPSULE;ORAL - 0.175MG, CAPSULE;ORAL - 0.1MG, CAPSULE;ORAL - 0.2MG

TABLET;ORAL - 0.0125MG;0.0031MG
TABLET;ORAL - 0.025MG;0.0063MG
TABLET;ORAL - 0.05MG;0.0125MG
TABLET;ORAL - 0.15MG;0.0375MG
TABLET;ORAL - 0.1MG;0.025MG
POWDER;INTRAVENOUS - 100MCG/VIAL
POWDER;INTRAVENOUS - 200MCG/VIAL
POWDER;INTRAVENOUS - 500MCG/VIAL
TABLET;ORAL - 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
CAPSULE;ORAL - 0.013MG
CAPSULE;ORAL - 0.025MG
CAPSULE;ORAL - 0.0375MG
CAPSULE;ORAL - 0.044MG
CAPSULE;ORAL - 0.05MG
CAPSULE;ORAL - 0.0625MG
CAPSULE;ORAL - 0.075MG
CAPSULE;ORAL - 0.088MG
CAPSULE;ORAL - 0.112MG
CAPSULE;ORAL - 0.125MG
CAPSULE;ORAL - 0.137MG
CAPSULE;ORAL - 0.15MG
CAPSULE;ORAL - 0.175MG
CAPSULE;ORAL - 0.1MG
CAPSULE;ORAL - 0.2MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 2 Rochem International Inc, 21 SPI Pharma, 9 DKSH, 8 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 ACG Worldwide, 6 Actylis, 2 Aeon Procare, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 16 BASF, 10 Corel Pharma Chem, 6 DFE Pharma, 1 Finar, 7 Gangwal Chemicals, 4 Ideal Cures, 5 Ingredion Pharma Solutions, 31 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 9 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 31 Roquette, 7 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 5 Silverline Chemicals, 2 The Dow Chemical Company, 1 Valens Pharmachem, 5 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

88 Fillers, Diluents & Binders, 42 Coating Systems & Additives, 32 Direct Compression, 31 Disintegrants & Superdisintegrants, 26 Thickeners and Stabilizers, 26 Granulation, 24 Controlled & Modified Release, 23 Taste Masking, 20 Parenteral, 19 Lubricants & Glidants, 19 Co-Processed Excipients, 18 Chewable & Orodispersible Aids, 15 Solubilizers, 9 Empty Capsules, 8 Film Formers & Plasticizers, 7 API Stability Enhancers, 7 Topical, 6 Emulsifying Agents, 5 Rheology Modifiers, 4 Vegetarian Capsules, 2 Coloring Agents, 1 Surfactant & Foaming Agents

88 Fillers, Diluents & Binders
42 Coating Systems & Additives
32 Direct Compression
31 Disintegrants & Superdisintegrants
26 Thickeners and Stabilizers
26 Granulation
24 Controlled & Modified Release
23 Taste Masking
20 Parenteral
19 Lubricants & Glidants
19 Co-Processed Excipients
18 Chewable & Orodispersible Aids
15 Solubilizers
9 Empty Capsules
8 Film Formers & Plasticizers
7 API Stability Enhancers
7 Topical
6 Emulsifying Agents
5 Rheology Modifiers
4 Vegetarian Capsules
2 Coloring Agents
1 Surfactant & Foaming Agents

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 92 News #PharmaBuzz

1 Data Compilation #PharmaFlow
92 News #PharmaBuzz

GLOBAL SALES INFORMATION

8 US Medicaid Prescriptions, 175 Regulatory FDF Prices, 8 Annual Reports

8 US Medicaid Prescriptions
175 Regulatory FDF Prices
8 Annual Reports

MARKET PLACE

30 APIs, 14 FDF Dossiers

30 APIs
14 FDF Dossiers

PATENTS & EXCLUSIVITIES

101 US Patents

101 US Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 2 USP, 3 Others

3 EDQM
2 USP
3 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 6,239 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

41 All

01 4ASPEN PHARMACARE CANADA INC.

02 12APOTEX INC

03 2AVIR PHARMA INC.

04 12BGP PHARMA ULC

05 3FRESENIUS KABI CANADA LTD

06 8LLOYD INC. OF IOWA

filter Active Ingredients Reset all filters

41 All

01 41LEVOTHYROXINE SODIUM

filter Dosage Form Reset all filters

41 All

01 3POWDER FOR SOLUTION

02 2SOLUTION

03 36TABLET

filter Brand Name Reset all filters

41 All

01 12APO-LEVOTHYROXINE

02 4ELTROXIN

03 3LEVOTHYROXINE SODIUM FOR INJECTION

04 2LEVOTHYROXINE SODIUM INJECTION

05 12SYNTHROID

06 8THYRO-TABS CANINE

List of Suppliers

Product Main Page

01

ASPEN PHARMACARE CANADA INC.

The Aesthetic Show

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Contact Supplier

Contact Supplier

Digital Content

Regulatory Info :

Registration Country : Canada

LEVOTHYROXINE SODIUM

Brand Name : ELTROXIN

Dosage Form : TABLET

Dosage Strength : 50MCG

Packaging : 500

Approval Date :

Application Number : 2213192

Regulatory Info :

Registration Country : Canada

Aspen API Comapny Banner

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

ASPEN PHARMACARE CANADA INC.

The Aesthetic Show

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Contact Supplier

Contact Supplier

Digital Content

Regulatory Info :

Registration Country : Canada

LEVOTHYROXINE SODIUM

Brand Name : ELTROXIN

Dosage Form : TABLET

Dosage Strength : 100MCG

Packaging : 500

Approval Date :

Application Number : 2213206

Regulatory Info :

Registration Country : Canada

Aspen API Comapny Banner

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

ASPEN PHARMACARE CANADA INC.

The Aesthetic Show

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Contact Supplier

Contact Supplier

Digital Content

Regulatory Info :

Registration Country : Canada

LEVOTHYROXINE SODIUM

Brand Name : ELTROXIN

Dosage Form : TABLET

Dosage Strength : 150MCG

Packaging : 500

Approval Date :

Application Number : 2213214

Regulatory Info :

Registration Country : Canada

Aspen API Comapny Banner

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

ASPEN PHARMACARE CANADA INC.

The Aesthetic Show

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Contact Supplier

Contact Supplier

Digital Content

Regulatory Info :

Registration Country : Canada

LEVOTHYROXINE SODIUM

Brand Name : ELTROXIN

Dosage Form : TABLET

Dosage Strength : 200MCG

Packaging : 500

Approval Date :

Application Number : 2213222

Regulatory Info :

Registration Country : Canada

Aspen API Comapny Banner

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

BGP PHARMA ULC

The Aesthetic Show

Not Confirmed

BGP PHARMA ULC

The Aesthetic Show

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

LEVOTHYROXINE SODIUM

Brand Name : SYNTHROID

Dosage Form : TABLET

Dosage Strength : 50MCG

Packaging : 90/1000

Approval Date :

Application Number : 2172070

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

BGP PHARMA ULC

The Aesthetic Show

Not Confirmed

BGP PHARMA ULC

The Aesthetic Show

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

LEVOTHYROXINE SODIUM

Brand Name : SYNTHROID

Dosage Form : TABLET

Dosage Strength : 25MCG

Packaging : 90/1000

Approval Date :

Application Number : 2172062

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

BGP PHARMA ULC

The Aesthetic Show

Not Confirmed

BGP PHARMA ULC

The Aesthetic Show

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

LEVOTHYROXINE SODIUM

Brand Name : SYNTHROID

Dosage Form : TABLET

Dosage Strength : 112MCG

Packaging : 90/1000

Approval Date :

Application Number : 2171228

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

BGP PHARMA ULC

The Aesthetic Show

Not Confirmed

BGP PHARMA ULC

The Aesthetic Show

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

LEVOTHYROXINE SODIUM

Brand Name : SYNTHROID

Dosage Form : TABLET

Dosage Strength : 125MCG

Packaging : 90/1000

Approval Date :

Application Number : 2172119

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

BGP PHARMA ULC

The Aesthetic Show

Not Confirmed

BGP PHARMA ULC

The Aesthetic Show

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

LEVOTHYROXINE SODIUM

Brand Name : SYNTHROID

Dosage Form : TABLET

Dosage Strength : 75MCG

Packaging : 90/1000

Approval Date :

Application Number : 2172089

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

BGP PHARMA ULC

The Aesthetic Show

Not Confirmed

BGP PHARMA ULC

The Aesthetic Show

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

LEVOTHYROXINE SODIUM

Brand Name : SYNTHROID

Dosage Form : TABLET

Dosage Strength : 300MCG

Packaging : 90/1000

Approval Date :

Application Number : 2172151

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3
Last

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!